Citi Depositary Receipt Services Year End 2020 Report

DR Follow-On Offerings 1 Issuer Country Industry 2 USD Value (in Millions) Pinduoduo Inc. China Consumer Discretionary $4,126 Nio Inc China Auto & Components $3,050 Sea Limited Singapore Consumer Services $2,574 XPeng Inc.* China Auto & Components $2,484 KE Holdings Inc. China Real Estate $2,361 Nio Inc China Auto & Components $1,730 Li Auto Inc. China Auto & Components $1,363 Ascendis Pharma A/S Denmark Pharmaceuticals, Biotech $690 Luckin Coffee Inc. China Food & Staples Retailing $667 argenx Netherlands Pharmaceuticals, Biotech $642 Yageo Corporation* Taiwan Electronics $553 BioNTech SE Germany Pharmaceuticals, Biotech $512 Kingsoft Cloud Holdings Limited China Software & Services $509 Dada Nexus Limited China Retailing $450 Nio Inc China Auto & Components $428 21 Vianet Group, Inc.* China Software & Services $406 OneConnect Financial Technology Co., Ltd. China Financials $373 BeiGene, Ltd.* China Pharmaceuticals, Biotech $367 Zai Lab Limited* China Pharmaceuticals, Biotech $328 Futu Holdings Limited China Financials $314 Jumia Technologies AG Germany Retailing $294 Adaptimmune Therapeutics plc* UK Pharmaceuticals, Biotech $259 Natura & Co Holding Brazil Household & Pers Prods $206 JSC NAC Kazatomprom* Kazakhstan Energy $197 Mail.ru Group Limited* Russia Information Technology $175 Avadel Pharmaceuticals Plc Ireland Pharmaceuticals, Biotech $125 Hutchison China MediTech Limited Hong Kong Pharmaceuticals, Biotech $118 Global DR Capital Raisings (cont.) *Signifies Citi DR program capital raising. IPO Deals in bold italics signify a JOBS Act Deal 1 Defined as capital raising at the time of listing of additional DR securities including rights offerings, at-the-market offerings, block sales, and private placements. Data as of December 31, 2020. 2 Industry as defined by Bloomberg. Source: Bloomberg and Depositary Data Interchange. 14